Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5900502 | Diabetes Research and Clinical Practice | 2011 | 5 Pages |
Abstract
We performed a study in 102 people with type 2 diabetes aiming to determine “easy-to-use” predictive factors for glycemic response to glitazones. We found that low baseline HDL-cholesterol (<40 mg/L [1.04 mmol/L] in males, <50 mg/L [1.30 mmol/L] in females) was a strong independent predictor of glycemic response to glitazones (OR = 2.67 [2.02-3.52], p = 0.0004).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Bruno Vergès, Laura Radu, Sabine Baillot-Rudoni, Marie-Claude Brindisi, Alix Poussier, Benjamin Bouillet, Jean-Michel Petit, Laurence Duvillard,